We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+23.72%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$17.4B
AUM Growth
+$2.72B
Cap. Flow
-$393M
Cap. Flow %
-2.26%
Top 10 Hldgs %
20.41%
Holding
131
New
5
Increased
72
Reduced
45
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 24.44%
2 Technology 22.73%
3 Financials 13.1%
4 Consumer Staples 12.5%
5 Industrials 11.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASAN icon
76
Asana
ASAN
$1.83B
$98.3M 0.56%
+3,325,340
New +$85M
WST icon
77
West Pharmaceutical
WST
$23.9B
$97.9M 0.56%
345,730
-167,645
-33% -$47M
ELF icon
78
e.l.f. Beauty
ELF
$4.85B
$93.2M 0.54%
3,700,843
+107,175
+3% +$2.3M
INDB icon
79
Independent Bank
INDB
$4.02B
$92.7M 0.53%
1,269,733
+31,965
+3% +$2.08M
JJSF icon
80
J&J Snack Foods
JJSF
$1.44B
$90.5M 0.52%
582,795
+241,795
+71% +$35.2M
ARGO
81
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$87.7M 0.5%
2,006,523
+166,975
+9% +$6.66M
PBH icon
82
Prestige Consumer Healthcare
PBH
$2.37B
$87.2M 0.5%
2,500,410
+72,930
+3% +$2.59M
CHD icon
83
Church & Dwight Co
CHD
$23.1B
$85M 0.49%
973,954
+379,205
+64% +$33.6M
PEN icon
84
Penumbra
PEN
$12.6B
$81.9M 0.47%
468,095
+68,485
+17% +$15M
EYE icon
85
National Vision
EYE
$1.79B
$78.8M 0.45%
1,739,820
+43,240
+3% +$1.88M
IOSP icon
86
Innospec
IOSP
$2.12B
$73.4M 0.42%
808,995
+47,630
+6% +$3.69M
PS
87
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$71M 0.41%
3,385,395
+1,567,095
+86% +$28M
GMED icon
88
Globus Medical
GMED
$10.9B
$70.3M 0.4%
1,078,545
+35,995
+3% +$2.07M
MGPI icon
89
MGP Ingredients
MGPI
$380M
$67.4M 0.39%
1,431,745
+52,900
+4% +$2.28M
WK icon
90
Workiva
WK
$3.29B
$65.3M 0.38%
713,220
-315,420
-31% -$22.2M
OMCL icon
91
Omnicell
OMCL
$1.69B
$65.2M 0.37%
543,095
-42,520
-7% -$4.17M
JRVR icon
92
James River Group Holdings
JRVR
$207M
$65M 0.37%
1,321,475
+54,260
+4% +$2.62M
SBH icon
93
Sally Beauty Holdings
SBH
$1.46B
$64.9M 0.37%
4,973,350
+151,730
+3% +$1.62M
CBU icon
94
Community Bank
CBU
$3.42B
$64.6M 0.37%
1,036,070
+32,095
+3% +$1.97M
TCMD icon
95
Tactile Systems Technology
TCMD
$636M
$63.6M 0.37%
1,415,535
+209,090
+17% +$8.31M
PLMR icon
96
Palomar
PLMR
$3.61B
$62.5M 0.36%
703,175
+154,525
+28% +$13M
BGS icon
97
B&G Foods
BGS
$293M
$58.5M 0.34%
2,109,890
-422,260
-17% -$11.9M
BL icon
98
BlackLine
BL
$1.8B
$56.9M 0.33%
426,815
-168,850
-28% -$18.8M
ENV
99
DELISTED
ENVESTNET, INC.
ENV
$56.8M 0.33%
690,205
+16,865
+3% +$1.36M
RBA icon
100
RB Global
RBA
$20.5B
$52.1M 0.3%
749,090
-168,010
-18% -$11.1M

Similar funds

Champlain Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Champlain Investment Partners held 131 positions worth $17.4B, up 18% from $14.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners's Q4 2020 filing shows 5 new, 72 increased, 45 reduced and 9 closed positions. Its largest new stake was Terminix Global Holdings, Inc.: 2,158,201 shares worth $110M. The largest sale was CATALENT, INC., an estimated $191M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

  • Champlain Investment Partners's largest Q4 2020 buy was Terminix Global Holdings, Inc.: 2,158,201 shares worth $110M.
  • Champlain Investment Partners added most to Generac Holdings in Q4 2020, an estimated $106M increase.
  • Champlain Investment Partners's biggest Q4 2020 reduction was CATALENT, INC., cutting an estimated $191M.
  • Champlain Investment Partners fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $148M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $17.4B portfolio in Q4 2020.
  • Champlain Investment Partners opened 5 new positions and closed 9 in Q4 2020.
  • Champlain Investment Partners's portfolio value rose 18% quarter-over-quarter to $17.4B.

Based on Champlain Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.